"Die Helios Kliniken Schwerin bestehen aus der Somatik (Neubau) mit rund 1.200 Betten und der Carl-Friedrich-Flemming-Klinik (historisches Gebäudeensemble), kurz CFFK mit rund 320 Betten. In der Somatik widmen wir uns körperlichen Beschwerden in der CFFK wird das gesamte Spektrum psychischer Erkrankungen behandelt."

During the past decade, Helios Kliniken Schwerin conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helios Kliniken Schwerin" #1 sponsor was "University Hospital Schleswig-Holstein" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 2 trials sponsored, "Leipzig Heart Institute GmbH" with 2 trials sponsored and "Universitätsklinikum Hamburg-Eppendorf" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helios Kliniken Schwerin" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "University of Luebeck" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Helios Kliniken Schwerin" are "Breast Cancer" (2 trials), "Leukemia" (2 trials), "Lymphoma" (2 trials), "Melanoma" (2 trials) and "Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Helios Kliniken Schwerin" in a lesser frequency.

Most popular intervention types in "Helios Kliniken Schwerin" are "Drug" (16 trials), "Radiation" (9 trials), "Biological" (7 trials), "Procedure" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "etoposide" (3 trials) and "ifosfamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Helios Kliniken Schwerin" are 25 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Helios Kliniken Schwerin". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Helios Kliniken Schwerin, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Helios Kliniken Schwerin, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".

Helios Kliniken Schwerin has several departments that took part in Clinical trials: "Hanse-Klinikum Stralsund - Krankenhaus West" - 2 trials